Drug Shortage Report for TOBRAMYCIN FOR INJECTION USP

Last updated on 2019-03-29 History
Report ID 39011
Drug Identification Number 02285150
Brand name TOBRAMYCIN FOR INJECTION U.S.P.
Common or Proper name TOBRAMYCIN FOR INJECTION U.S.P.
Company Name STERIMAX INC
Market Status DORMANT
Active Ingredient(s) TOBRAMYCIN
Strength(s) 1.2G
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS
Packaging size 6 VIALS
ATC code J01GB
ATC description AMINOGLYCOSIDE ANTIBACTERIALS
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2018-02-05
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2019-03-29
Company comments Manufacturer changes
Health Canada comments
Tier 3 Status No
Contact Address 2770 PORTLAND DRIVE
OAKVILLE, ONTARIO
CANADA L6H 6R4
Company contact information 1-800-881-3550

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2018-02-07 English Compare
v2 2018-02-07 English Compare
v3 2018-02-07 French Compare
v4 2018-03-20 English Compare
v5 2018-03-20 French Compare
v6 2019-03-29 English Compare
v7 2019-03-29 English Compare
v8 2019-03-29 French Compare

Showing 1 to 8 of 8